Salmeterol and Fluticasone Propionate Powder for Inhalation IP​ | AIRFLOW 50 INH

Description

Salmeterol and Fluticasone Propionate Powder for Inhalation IP Salmeterol and Fluticasone Propionate Powder for Inhalation IP is a combination medication used to manage and prevent symptoms of asthma and Chronic Obstructive Pulmonary Disease (COPD). It combines the long-acting bronchodilator Salmeterol with the corticosteroid Fluticasone Propionate, offering dual action — bronchodilation and anti-inflammatory relief — for easier, controlled breathing. Formulated as an inhalation powder, this medicine delivers the active ingredients directly into the lungs, ensuring faster onset of action, minimal systemic absorption, and improved lung function over time. Composition and Mechanism of Action Each dose of Fluticasone Propionate and Salmeterol Inhalation Powder contains: Fluticasone Propionate: A synthetic corticosteroid that reduces airway inflammation, swelling, and irritation. Salmeterol: A long-acting beta-2 agonist (LABA) that relaxes the muscles around the airways, making breathing easier and preventing bronchospasms. Together, Fluticasone and Salmeterol Inhaler provide 24-hour protection against breathing difficulties by controlling both the root cause (inflammation) and symptoms (airway tightening). Uses of Salmeterol and Fluticasone Propionate Inhaler This medication is commonly prescribed for: Asthma management in adults and adolescents. Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. Prevention of asthma attacks triggered by exercise or allergens. Improving lung function and reducing the frequency of exacerbations. The Fluticasone Propionate and Salmeterol Inhaler helps patients maintain normal breathing throughout the day and night, improving overall respiratory health and quality of life. Key Benefits Dual Mechanism for Strong Relief: Combines anti-inflammatory and bronchodilatory effects for complete asthma and COPD control. Long-Lasting Effect: Provides up to 12 hours of symptom relief, ensuring consistent airflow. Targeted Lung Delivery: Powder formulation acts directly on the lungs, reducing systemic side effects. Prevents Flare-Ups: Regular use minimizes asthma attacks and COPD exacerbations. Improved Exercise Tolerance: Helps patients breathe freely during physical activity. How to Use Inhale the powder through the prescribed inhaler device exactly as directed by your physician. Use it twice daily (morning and evening) for best results. Rinse your mouth with water after inhalation to avoid oral thrush or throat irritation. Do not exceed the recommended dose. Possible Side Effects While Fluticasone Propionate and Salmeterol Inhalation Powder is generally well-tolerated, some individuals may experience: Hoarseness or sore throat Headache or mild tremor Oral thrush (fungal infection in mouth) Muscle cramps or cough Nausea or dizziness Most of these effects are mild and temporary. If symptoms persist or worsen, consult your healthcare provider immediately. Safety Advice Not intended for acute asthma attacks — use a rescue inhaler for sudden symptoms. Inform your doctor if you have heart disease, diabetes, or hypertension. Avoid abruptly stopping the medicine without medical advice. For long-term use, periodic lung function monitoring is recommended. Conclusion Salmeterol and Fluticasone Propionate Powder for Inhalation IP is a clinically proven and widely trusted therapy for patients struggling with asthma and COPD. By combining two powerful agents — Fluticasone Propionate (a corticosteroid) and Salmeterol (a bronchodilator) — this inhalation powder ensures effective, long-term respiratory management. It not only relieves current symptoms but also prevents future flare-ups, allowing patients to lead a more active and unrestricted lifestyle. Always use this medication under the supervision of a qualified physician for the best outcomes.